ArticleNature biotechnology2010
Chimeric mouse tumor models reveal differences in pathway activation between ERBB family- and KRAS-dependent lung adenocarcinomas.
Yinghui Zhou et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
40 papers cite it
this papercites it